Literature DB >> 12855944

HIV diagnoses among injection-drug users in states with HIV surveillance--25 states, 1994-2000.

.   

Abstract

Injection-drug use is a risk factor for acquired immunodeficiency syndrome (AIDS). Of the 765,559 cumulative AIDS cases diagnosed as of December 2000, a total of 193,527 (25%) occurred among injection-drug users (IDUs). IDUs become infected with human immunodeficiency virus (HIV) through sharing injection-drug equipment with HIV-infected persons or by engaging in other risk behaviors such as having unprotected sex. Since 1995, AIDS incidence among IDUs has declined. This report presents data on initial HIV diagnoses among IDUs aged >/=13 years, with and without AIDS at the time of HIV diagnosis, by year, during 1994--2000. The findings indicate that HIV diagnoses among IDUs have leveled in the majority of demographic groups during this period in the 25 states for which HIV surveillance data are available. Because IDUs and their sex partners represent approximately one third of persons infected in the HIV epidemic and continue to be at risk for transmitting HIV, prevention efforts targeting IDUs and their sex partners should be enhanced.

Entities:  

Mesh:

Year:  2003        PMID: 12855944

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  28 in total

1.  Injection drug use among stimulant users in a national sample.

Authors:  Li-Tzy Wu; Daniel J Pilowsky; Wendee M Wechsberg; William E Schlenger
Journal:  Am J Drug Alcohol Abuse       Date:  2004       Impact factor: 3.829

2.  Public funding of US syringe exchange programs.

Authors:  Don C Des Jarlais; Courtney McKnight; Judith Milliken
Journal:  J Urban Health       Date:  2004-03       Impact factor: 3.671

3.  Changes in HIV and AIDS in the United States: Entering the Third Decade.

Authors:  Scott Kellerman; Elin Begley; Brian Boyett; Hollie Clark; Jeff Schulden
Journal:  Curr Infect Dis Rep       Date:  2005-03       Impact factor: 3.725

Review 4.  Changes in HIV and AIDS in the United States: entering the third decade.

Authors:  Scott Kellerman; Elin Begley; Brian Boyett; Hollie Clark; Jeff Schulden
Journal:  Curr HIV/AIDS Rep       Date:  2004-12       Impact factor: 5.071

5.  Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003.

Authors:  Ryan J Deibert; Gary Goldbaum; Theodore R Parker; Holly Hagan; Robert Marks; Michael Hanrahan; Hanne Thiede
Journal:  Am J Public Health       Date:  2006-06-29       Impact factor: 9.308

6.  HIV counseling and testing among injection drug users needs to continue.

Authors:  Curt G Beckwith; Nickolas Zaller; Timothy P Flanigan
Journal:  Am J Public Health       Date:  2007-05-30       Impact factor: 9.308

7.  Nurse practitioner and physician assistant interest in prescribing buprenorphine.

Authors:  Robert J Roose; Hillary V Kunins; Nancy L Sohler; Rashiah T Elam; Chinazo O Cunningham
Journal:  J Subst Abuse Treat       Date:  2007-07-30

8.  Short communication: Lack of immune response in rapid progressor morphine-dependent and SIV/SHIV-infected rhesus macaques is correlated with downregulation of TH1 cytokines.

Authors:  Vanessa Rivera-Amill; Rakesh Kumar; Richard J Noel; Yashira Garcia; Idia V Rodriguez; Melween Martinez; Carlos A Sariol; Edmundo Kraiselburd; Marcus Iszard; Mridul Mukherji; Santosh Kumar; Luis D Giavedoni; Anil Kumar
Journal:  AIDS Res Hum Retroviruses       Date:  2010-08       Impact factor: 2.205

Review 9.  Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States.

Authors:  Scott S Santibanez; Richard S Garfein; Andrea Swartzendruber; David W Purcell; Lynn A Paxton; Alan E Greenberg
Journal:  J Urban Health       Date:  2006-01       Impact factor: 3.671

10.  Lessons learned from a peri-urban needle exchange.

Authors:  Andrea K Knittel; Patricia A Wren; Lemont Gore
Journal:  Harm Reduct J       Date:  2010-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.